Functional gastrointestinal disorders and irritable bowel syndrome
Functional gastrointestinal disorders (FGIDs) are common conditions seen in the pharmacy. This article will discuss the specific management of one of the most prevalent FGIDs—irritable bowel syndrome (IBS). By Lyndel …
Managing eczema in infants and children
Pharmacists are often consulted by parents and caregivers about the management of eczema in their young children. In this article, Marsha Gomez provides the latest information about the management of …
Adverse drug reactions
Adverse drug reactions (ADRs) are unintended and harmful effects that occur when a medication is administered at a standard dosage. While medications play a vital role in modern healthcare, their …
Record numbers to sit intern written exam
Australia’s pharmacy workforce set for boost with close to 1500 candidates set to sit the Australian Pharmacy Council’s intern written exam in October Moves towards rebuilding the pharmacy workforce following …
Seek succession opportunities
Aspiring pharmacy owners are being urged to approach older proprietors about working their way into ownership, a Guild leader says More young women should be involved in pharmacy ownership, Judy …
Getting to zero
In a difficult financial climate, following a ‘winter downshift’ and with 60-day dispensing kicking off, the challenge is immense for pharmacies to achieve growth in 2023/24. But it can be …
Week in review
Pharmacist prescribing trials captured the headlines this week, while pharmaceutical wholesaler, Sigma Healthcare, reported that 60-day dispensing is having little impact on its business Recruitment of pharmacists to participate in …
Immune health: the impact of Covid
Covid seems to have had long-term impacts on the immune system of many sufferers. Evidence is gradually emerging on how and why this may be happening What are the links …
No new Ozempic scripts: TGA
Prescribers urged not to start new patients on Ozempic, as Novo Nordisk warns of supply shortages throughout 2024 Ozempic supplier, Novo Nordisk, is warning that supply of the diabetes medication …
Private label to drive retail growth: Sigma
Wholesaler plans to shift its retail strategy from consolidation to growth, with private label products set to play a key role Having consolidated its community pharmacy franchises under two brands …
Corum name change approved
Shareholders green light sale of Corum Group’s pharmacy software business, and new company name Australian Securities Exchange (ASX) listed pharmacy IT solutions firm Corum Group has received near unanimous support …
